LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹152 Cr | ₹186 Cr | ₹174 Cr | ₹188 Cr | ₹203 Cr |
What is the latest Total Liabilities ratio of LYKA LABS ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹152 Cr |
Mar2022 | ₹186 Cr |
Mar2021 | ₹174 Cr |
Mar2020 | ₹188 Cr |
Mar2019 | ₹203 Cr |
How is Total Liabilities of LYKA LABS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹152 Cr | -18.37 | |
Mar2022 | ₹186 Cr | 6.88 | |
Mar2021 | ₹174 Cr | -7.57 | |
Mar2020 | ₹188 Cr | -7.38 | |
Mar2019 | ₹203 Cr | - |
Compare Total Liabilities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹363.3 Cr | -6% | -14.1% | 12.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | -6% |
-14.1% |
12.9% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses